https://doi.org/10.1016/j.celrep.2020.108500
J
Jason Stadanlick
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
98
Papers
2.4K
Citations
25
h-index
26
i10-index
Jason Stadanlick is an academic researcher. The author has contributed to research in topics: Immune cells in cancer & Blood disorders and treatments & Immune Cell Function and Interaction. The author has an h-index of 25, co-authored 84 publications.
ORCID: 0000-0003-1112-6736Papers by this author
worksLactate Limits T Cell Proliferation via the NAD(H) Redox State
2020 · Cell Reports · 320 citations
Neoadjuvant Gene-Mediated Cytotoxic Immunotherapy for Non-Small-Cell Lung Cancer: Safety and Immunologic Activity
2020 · Molecular Therapy · 33 citations
https://doi.org/10.1016/j.ymthe.2020.11.001
OP0202 RESET-SLE: CLINICAL TRIAL EVALUATING RESE-CEL (RESECABTAGENE AUTOLEUCEL), A FULLY HUMAN, AUTOLOGOUS 4-1BB ANTI-CD19 CAR T CELL THERAPY IN NON-RENAL SLE AND LUPUS NEPHRITIS
2025 · Annals of the Rheumatic Diseases · 5 citations
https://doi.org/10.1016/j.ard.2025.05.214
Case study of resecabtagene autoleucel in a subject with diffuse cutaneous systemic sclerosis treated in the RESET-SSc trial
2025 · Molecular Therapy Advances · 1 citations
https://doi.org/10.1016/j.omta.2025.201663
Supplementary Figure S9 from Human Tumor–Associated Macrophages and Neutrophils Regulate Antitumor Antibody Efficacy through Lethal and Sublethal Trogocytosis
2024 · 0 citations
https://doi.org/10.1158/0008-5472.25515601.v1
Supplementary Table S1 from Human Tumor–Associated Macrophages and Neutrophils Regulate Antitumor Antibody Efficacy through Lethal and Sublethal Trogocytosis
2024 · 0 citations
https://doi.org/10.1158/0008-5472.25515595
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat